Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
This article summarizes the most significant insider buying and selling activities reported on Wednesday for US stocks.
Top Insider Buys:
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) saw Director Dennis Langer purchase 15,152 ADSs at $8.49 per share on October 14, 2025, for a total transaction value of $128,640. Langer also acquired an equal number of Series H, I, J, and K Warrants, all bundled with the ADSs at the combined price of $8.49. This insider buy comes as QNRX stock has shown strong momentum, gaining over 70% in the past week and trading near $15.27. Analysts maintain a bullish outlook with price targets ranging from $25 to $70.
Commercial Bancgroup, Inc. (NASDAQ:CBK) Director James J. Shoffner acquired 14,583 shares of common stock at $24.0 per share on October 3, 2025, totaling $349,992. Following the transaction, Shoffner directly owns 14,583 shares of the $338 million market cap financial institution. The stock is currently trading near its 52-week low of $23.36, with a P/E ratio of 9.2.
Resources Connection, Inc. (NASDAQ:RGP) President and CEO Kate W. Duchene purchased 23,015 shares at a weighted average price of $4.3646 on October 15, 2025, for a total transaction value of $100,451. The insider buy comes as RGP trades near its 52-week low of $4.23. Following the transaction, Duchene directly owns 590,233.9079 shares of Resources Connection.
Volitionrx LTD (NASDAQ:VNRX) Director Timothy Still acquired 48,076 shares of common stock at $0.51 per share on October 14, 2025, totaling $24,518. Still also purchased warrants to buy 48,076 shares at an exercise price of $0.60, expiring on October 14, 2030. These warrants were acquired for $0.01 per warrant.
Volitionrx LTD (NASDAQ:VNRX) Director Guy Archibald Innes purchased 96,153 shares of common stock at $0.51 per share on October 14, 2025, for a total value of $49,038. Innes also acquired 96,153 warrants to buy common stock at $0.01 per warrant. The purchases come as VNRX trades near its 52-week low of $0.40, having declined nearly 29% in the past week.
Top Insider Sells:
Vistra Corp (NYSE:VST) CEO James A. Burke sold a total of $17.2 million in common stock between October 10 and October 14, 2025, at prices ranging from $201.12 to $209.76 per share. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan and involved multiple sales totaling 84,160 shares.
CoreWeave, Inc. (NASDAQ:CRWV) saw Magnetar Financial LLC, along with related entities, sell shares of Class A Common Stock amounting to $52,183,135 on October 13, 2025. The sales involved 364,579 shares at prices ranging from $140.14 to $143.28 per share.
Grindr Inc. (NYSE:GRND) Director Lu James Fu Bin, a ten percent owner, sold 649,900 shares of common stock in three separate transactions between October 10 and October 13, 2025, totaling approximately $8.1 million. The sales were executed at prices ranging from $11.94 to $13.22 per share.
Servicetitan, Inc. (NASDAQ:TTAN) CEO Ara Mahdessian sold shares of Class A Common Stock worth approximately $6.2 million on October 13 and 14, 2025. The sales involved a total of 64,008 shares at prices ranging from $96.03 to $97.85 per share.
Nvidia (NASDAQ:NVDA) President and CEO Huang Jen Hsun sold a total of $41.3 million in common stock between October 13 and October 15, 2025. The sales, executed under a pre-arranged Rule 10b5-1 trading plan, involved multiple transactions with prices ranging from $178.1301 to $189.4587 per share.
Investors should stay tuned to insider buying and selling activities as they can provide valuable insights into a company’s prospects. While insider transactions alone should not be the sole basis for investment decisions, they can offer clues about management’s confidence in the company’s future performance or potential concerns. It’s important to consider these activities alongside other fundamental and technical analysis when evaluating investment opportunities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.